BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 33549463)

  • 1. Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation.
    Zhang X; He Y; Li X; Shraim R; Xu W; Wang L; Farrington SM; Campbell H; Timofeeva M; Zgaga L; Vaughan-Shaw P; Theodoratou E; Dunlop MG
    Br J Cancer; 2024 May; 130(9):1585-1591. PubMed ID: 38480934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).
    Blinder VS; Deal AM; Ginos B; Jansen J; Dueck AC; Mazza GL; Henson S; Carr P; Rogak LJ; Weiss A; Rapperport A; Jonsson M; Spears PA; Cella D; Gany F; Schrag D; Basch E
    J Clin Oncol; 2023 Oct; 41(29):4652-4663. PubMed ID: 37625107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What percentage of patients with cancer develop hiccups with oxaliplatin- or cisplatin-based chemotherapy? a compilation of patient-reported outcomes.
    Ehret C; Martin NA; Jatoi A
    PLoS One; 2023; 18(1):e0280947. PubMed ID: 36706101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and Acceptability of Implementing Site-Specific Patient-Reported Outcome Measure in Head and Neck Cancer Clinics: A Prospective Institutional Study.
    Al-Rashdan A; Grendarova P; Yannitsos D; Quon H; Banerjee R; Barbera L
    Adv Radiat Oncol; 2022; 7(6):101036. PubMed ID: 36420192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
    Basch E; Schrag D; Henson S; Jansen J; Ginos B; Stover AM; Carr P; Spears PA; Jonsson M; Deal AM; Bennett AV; Thanarajasingam G; Rogak LJ; Reeve BB; Snyder C; Bruner D; Cella D; Kottschade LA; Perlmutter J; Geoghegan C; Samuel-Ryals CA; Given B; Mazza GL; Miller R; Strasser JF; Zylla DM; Weiss A; Blinder VS; Dueck AC
    JAMA; 2022 Jun; 327(24):2413-2422. PubMed ID: 35661856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a prediction model of poor performance status and severe symptoms over time in cancer patients (PROVIEW+).
    Seow H; Tanuseputro P; Barbera L; Earle CC; Guthrie DM; Isenberg SR; Juergens RA; Myers J; Brouwers M; Tibebu S; Sutradhar R
    Palliat Med; 2021 Oct; 35(9):1713-1723. PubMed ID: 34128429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Reported Functional Status in Outpatients With Advanced Cancer: Correlation With Physician-Reported Scores and Survival.
    Popovic G; Harhara T; Pope A; Al-Awamer A; Banerjee S; Bryson J; Mak E; Lau J; Hannon B; Swami N; Le LW; Zimmermann C
    J Pain Symptom Manage; 2018 Jun; 55(6):1500-1508. PubMed ID: 29496534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Patient-Reported Outcomes Into Prognostication in Gastroesophageal Cancer: Results of a Population-Based Retrospective Cohort Analysis.
    Baccili Cury Megid T; Sharma D; Baskurt Z; Xiaolu Ma L; Wang X; Barron CC; Jang RW; Chen EX; Swallow CJ; Mesci A; Yeung J; Wong RKS; Brar SS; Veit-Haibach P; Kim J; Bach Y; Aoyama H; Elimova E
    Oncologist; 2024 Apr; 29(4):316-323. PubMed ID: 38431782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG-PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer.
    Neeman E; Gresham G; Ovasapians N; Hendifar A; Tuli R; Figlin R; Shinde A
    Oncologist; 2019 Dec; 24(12):e1460-e1466. PubMed ID: 31227648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple prognostic model for patients with advanced cancer based on performance status.
    Jang RW; Caraiscos VB; Swami N; Banerjee S; Mak E; Kaya E; Rodin G; Bryson J; Ridley JZ; Le LW; Zimmermann C
    J Oncol Pract; 2014 Sep; 10(5):e335-41. PubMed ID: 25118208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
    Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
    Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Ability of Physician-Reported Versus Patient-Reported Performance Status to Predict Survival in a Population-Based Cohort of Newly Diagnosed Cancer Patients.
    Al-Rashdan A; Sutradhar R; Nazeri-Rad N; Yao C; Barbera L
    Clin Oncol (R Coll Radiol); 2021 Jul; 33(7):476-482. PubMed ID: 33549463
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.